Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial

This publication has 26 references indexed in Scilit:

• Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate1 1The trial was designed and the manuscript was written by Dr. Andriulli. No pharmaceutical or private grants were searched for or made available for performing the present work.
  Clinical Gastroenterology and Hepatology, 2004
• Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trial
  Gastrointestinal Endoscopy, 2002
• Ulinastatin in the treatment of acute pancreatitis: A multicenter clinical trial
  Chinese Journal of Digestive Diseases, 2002
• Complications of Endoscopic Biliary Sphincterotomy
  New England Journal of Medicine, 1996
• The Use of a Long-Acting Somatostatin Analogue (Octreotide) for Prophylaxis of Acute Pancreatitis after Endoscopic Sphincterotomy
  Endoscopy, 1994
• Endoscopic sphincterotomy complications and their management: an attempt at consensus
  Gastrointestinal Endoscopy, 1991
• Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis
  Digestive Diseases and Sciences, 1984
• Pancreatic injury following ERCP: Failure of prophylactic benefit of Trasylol®
  Gastrointestinal Endoscopy, 1977
• Effect of Calcitonin on the Serum Amylase Levels after Endoscopic Retrograde Cholangiopancreatography
  Digestion, 1977
• The role of glucagon in endoscopic cholangiopancreatography
  Gastrointestinal Endoscopy, 1975